Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Sleep Medicine · Narcolepsy Type 1

Is Narcolepsy Type 1 Hereditary? Should Relatives Get Tested?

At a Glance

Narcolepsy type 1 is usually not directly inherited. Family members have a slightly higher risk, but the overall risk remains low, so routine genetic testing of people without symptoms is not useful for prediction. Watch for symptoms and seek a sleep evaluation if they appear.

It is completely natural to worry about passing narcolepsy to your children or to wonder whether your siblings should be screened. The short answer is no, narcolepsy type 1 (NT1) is rarely directly inherited from a parent, and routine genetic testing for family members who do not have symptoms is not recommended. While having a relative with NT1 does increase a person’s risk slightly compared to the general population, the absolute risk remains very low [1]. Most people with NT1 do not have a family history of the disease.

The Difference Between Susceptibility and Inheritance

Narcolepsy type 1 is considered a complex, multifactorial condition rather than a simple inherited disorder [1]. This means that while genetic susceptibility sets the stage, it does not dictate the outcome.

Nearly all people with NT1 carry a specific genetic marker (or HLA allele) called HLA-DQB1*06:02 [2]. However, this marker is incredibly common, appearing in about 25% to 28% of the general population, though this prevalence varies by ancestry [3][4]. Having this marker simply means a person is more susceptible; it is neither necessary nor sufficient by itself to cause the disease [2].

The low familial risk is best demonstrated by twin studies. Even in identical twins, who share the exact same DNA, if one twin has NT1, the other twin will develop the condition only about 33% of the time [5]. It is widely believed that NT1 involves an immune-mediated loss of hypocretin-producing neurons in the brain, and that environmental factors may contribute to triggering the disease in genetically susceptible people [2]. However, the exact trigger is often unknown, and many patients cannot identify a specific event (like an infection) that caused their condition [5].

Why Testing Asymptomatic Relatives Isn’t Helpful

Because the HLA-DQB1*06:02 allele is so common, a positive blood test in a family member who feels fine cannot predict whether they will ever develop narcolepsy [6][7]. A positive result would only show that they, like a quarter of the general population, carry a susceptibility marker [3]. Conversely, a negative test reduces the likelihood but does not entirely eliminate the possibility of developing the condition [3][8].

As a result, routine HLA testing for unaffected family members does not predict who will develop NT1 well enough to guide prevention, and it often causes unnecessary worry [6].

What Family Members Should Do Instead

Instead of genetic screening, the most practical approach is symptom awareness. Symptoms usually appear during adolescence or young adulthood, but they can also start in childhood. Relatives should consult a primary care doctor or sleep specialist if they experience:

  • Excessive daytime sleepiness: An irresistible need to sleep or unintentional sleep episodes during the day, not just ordinary tiredness. In children, this may look like irritability, hyperactivity, or resuming unplanned naps [9].
  • Cataplexy: Sudden, brief episodes of muscle weakness triggered by strong emotions like laughter, surprise, or anger [9].
  • Sleep paralysis: A temporary inability to move or speak while falling asleep or waking up [9].
  • Sleep-related hallucinations: Vivid, sometimes frightening dreams or visions when transitioning between sleep and wakefulness. These occur at the edge of sleep and do not indicate psychosis [9].

(Safety Note: Anyone experiencing uncontrollable sleep episodes or unexplained daytime sleepiness should avoid driving or operating dangerous machinery until evaluated by a doctor).

If a family member develops these symptoms, a clinical evaluation is appropriate [10]. Diagnosing NT1 relies on clinical symptoms and objective sleep studies, such as polysomnography (an overnight sleep study) and a multiple sleep latency test (a daytime nap study) [9][11]. A specialist may sometimes measure hypocretin levels in the spinal fluid. Not every test is required for every patient, and a sleep specialist will choose the appropriate work-up.

While the vast majority of NT1 cases are not directly inherited, rare familial cases with multiple affected relatives or unusual early-onset symptoms do exist. In those specific situations, genetic counseling may be discussed [12].

Common questions in this guide

Is narcolepsy type 1 passed down from parents to children?
Narcolepsy type 1 is rarely passed directly from a parent to a child. It is a complex condition influenced by genetic susceptibility and other factors, so having an affected relative raises risk only slightly and the overall risk remains low. Most people with narcolepsy type 1 do not have a family history.
Should relatives without symptoms have genetic testing for narcolepsy?
Routine HLA testing is not recommended for relatives who have no symptoms. The HLA-DQB1*06:02 marker is common in the general population and cannot reliably predict whether someone will develop narcolepsy type 1. A positive result does not mean the person will develop the condition, and a negative result does not completely rule it out.
What signs of narcolepsy should family members watch for?
Family members should watch for irresistible daytime sleepiness or unplanned sleep episodes, sudden muscle weakness triggered by emotions, sleep paralysis, and vivid dreams or hallucinations at the edge of sleep. These symptoms warrant an evaluation by a primary care clinician or sleep specialist. Anyone with uncontrollable sleep episodes should avoid driving or dangerous machinery until evaluated.
Does carrying HLA-DQB1*06:02 mean someone will develop narcolepsy type 1?
No. The marker indicates susceptibility rather than a diagnosis or certainty, and it occurs in roughly one-quarter of the general population. Many people who carry it never develop narcolepsy, while the marker is not required in every person who develops narcolepsy type 1.
How is narcolepsy type 1 diagnosed if a relative develops symptoms?
Diagnosis is based on symptoms and objective sleep testing, usually an overnight polysomnography followed by a multiple sleep latency test. A sleep specialist may sometimes measure hypocretin in spinal fluid. The specialist chooses the tests based on the person's symptoms and situation.
When might a family need genetic counseling for narcolepsy?
Genetic counseling may be considered when several relatives are affected or when symptoms begin unusually early. Most families with one person who has narcolepsy type 1 do not need genetic testing of symptom-free relatives. A counselor can review the family history and explain what testing can and cannot show.

Get notified when new evidence is published on narcolepsy 1.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (12)
  1. 1

    Genetics of narcolepsy.

    Miyagawa T, Tokunaga K

    Human genome variation 2019; (6()):4 doi:10.1038/s41439-018-0033-7.

    PMID: 30652006
  2. 2

    Narcolepsy risk loci outline role of T cell autoimmunity and infectious triggers in narcolepsy.

    Ollila HM, Sharon E, Lin L, et al.

    Nature communications 2023; (14(1)):2709 doi:10.1038/s41467-023-36120-z.

    PMID: 37188663
  3. 3

    Correlation between HLA-DQB1*06:02 and narcolepsy with and without cataplexy: approving a safe and sensitive genetic test in four major ethnic groups. A systematic meta-analysis.

    Capittini C, De Silvestri A, Terzaghi M, et al.

    Sleep medicine 2018; (52()):150-157 doi:10.1016/j.sleep.2018.08.024.

    PMID: 30321823
  4. 4

    HLA high-resolution typing by next-generation sequencing in Pandemrix-induced narcolepsy.

    Lind A, Akel O, Wallenius M, et al.

    PloS one 2019; (14(10)):e0222882 doi:10.1371/journal.pone.0222882.

    PMID: 31577807
  5. 5

    Narcolepsy type 1: an environment-influenced disease.

    Vinceti B, Fusco C, Cordelli DM, Plazzi G

    Sleep medicine 2026; (146()):109034 doi:10.1016/j.sleep.2026.109034.

    PMID: 42258964
  6. 6

    Guidelines From the French-Speaking Society for Histocompatibility and Immunogenetics (SFHI) for Harmonisation of HLA Genotyping in Autoimmune Diseases, Drug Hypersensitivity and Pharmacogenetics.

    Renac V, Moalic V, Dautin G, et al.

    HLA 2025; (106(4)):e70442 doi:10.1111/tan.70442.

    PMID: 41137743
  7. 7

    Whole-genome analysis of monozygotic Brazilian twins discordant for type 1 narcolepsy: a case report.

    Campos JHC, Aguilar ACR, Antoneli F, et al.

    BMC neurology 2022; (22(1)):439 doi:10.1186/s12883-022-02921-w.

    PMID: 36401198
  8. 8

    A series of 7 cases of patients with narcolepsy with hypocretin deficiency without the HLA DQB1*06:02 allele.

    Miano S, Barateau L, De Pieri M, et al.

    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2023; (19(12)):2053-2057 doi:10.5664/jcsm.10748.

    PMID: 37539640
  9. 9

    [NARCOLEPSY WITH CATAPLEXY: TYPE 1 NARCOLEPSY].

    Dauvilliers Y, Lopez R

    La Revue du praticien 2016; (66(6)):671-6.

    PMID: 27538328
  10. 10

    Narcolepsy - clinical spectrum, aetiopathophysiology, diagnosis and treatment.

    Bassetti CLA, Adamantidis A, Burdakov D, et al.

    Nature reviews. Neurology 2019; (15(9)):519-539 doi:10.1038/s41582-019-0226-9.

    PMID: 31324898
  11. 11

    To diagnose narcolepsy type 1 after a negative multiple sleep latency test: the contribution of systematic hypocretin measurement.

    Biscarini F, Vandi S, Neccia G, et al.

    Sleep 2026; (49(9)) doi:10.1093/sleep/zsag142.

    PMID: 42189945
  12. 12

    Bi-allelic variants in HCRT cause autosomal recessive narcolepsy.

    Hakami W, Thabet F, Alhashem A, et al.

    Neurogenetics 2024; (25(2)):79-83 doi:10.1007/s10048-024-00744-0.

    PMID: 38240911

This page explains family risk and testing for narcolepsy type 1 for informational purposes only and does not constitute medical advice. A sleep specialist or genetic counselor can interpret your family history and symptoms.